𝛼SK or Search

ENTITY

Evommune (EVMN US)

4

Analysis

Health Care • United States

Evommune, Inc.operates as a clinical-stage biotechnology company. The Company focuses on the developing therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Evommune serves customers worldwide.

more

Refresh

Exchange Announcement • 01 Oct 2026 20:01

Current Report (Form 8-K | Period ending 2026-10-01)

Exchange Announcement • 24 Sep 2026 04:05

Current Report (Form 8-K | Period ending 2026-09-23)

Exchange Announcement • 15 Sep 2026 20:30

Current Report (Form 8-K | Period ending 2026-09-15)

Exchange Announcement • 07 Aug 2026 04:10

424B3 | Prospectus

Exchange Announcement • 07 Aug 2026 04:09

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x